domingo, 14 de mayo de 2017

A phase 2, randomized, double-blind, placebo- controlled study of chemo-immunotherapy combination using motolimod with pegylated liposomal doxorubicin in recurrent or persistent ovarian cancer: a Gynecologic Oncology Group partners study

https://phgkb.cdc.gov/GAPPKB/phgHome.do

BRCA

From HuGE Literature Finder Database
This database contains published literature on genetic associations and other human genome epidemiology

No hay comentarios:

Publicar un comentario